CN101772356B - 抗菌组合物 - Google Patents

抗菌组合物 Download PDF

Info

Publication number
CN101772356B
CN101772356B CN200880024342XA CN200880024342A CN101772356B CN 101772356 B CN101772356 B CN 101772356B CN 200880024342X A CN200880024342X A CN 200880024342XA CN 200880024342 A CN200880024342 A CN 200880024342A CN 101772356 B CN101772356 B CN 101772356B
Authority
CN
China
Prior art keywords
treatment
wounds
medicament
wound
burns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880024342XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101772356A (zh
Inventor
亚历山大·A·戈卢布
O·O·比莱瓦
V·V·内斯塔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN101772356A publication Critical patent/CN101772356A/zh
Application granted granted Critical
Publication of CN101772356B publication Critical patent/CN101772356B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/38—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/2404—Serralysin (3.4.24.40)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Composite Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CN200880024342XA 2007-07-12 2008-07-11 抗菌组合物 Expired - Fee Related CN101772356B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
UAU200707897 2007-07-12
UAU200707897U UA28103U (uk) 2007-07-12 2007-07-12 Комплексний сорбційно-протеолітичний препарат сертасил для лікування гнійних ран, трофічних виразок, опіків
PCT/UA2008/000041 WO2009008851A2 (en) 2007-07-12 2008-07-11 Antimicrobial composition

Publications (2)

Publication Number Publication Date
CN101772356A CN101772356A (zh) 2010-07-07
CN101772356B true CN101772356B (zh) 2013-05-08

Family

ID=55588706

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880024342XA Expired - Fee Related CN101772356B (zh) 2007-07-12 2008-07-11 抗菌组合物

Country Status (23)

Country Link
US (4) US9302027B2 (enExample)
EP (2) EP2170415B1 (enExample)
JP (1) JP5464750B2 (enExample)
KR (1) KR101482960B1 (enExample)
CN (1) CN101772356B (enExample)
AT (1) ATE488255T1 (enExample)
AU (1) AU2008275852B2 (enExample)
BR (1) BRPI0814549B1 (enExample)
CA (1) CA2693087C (enExample)
CY (1) CY1111652T1 (enExample)
DE (1) DE602008003584D1 (enExample)
DK (1) DK2170415T3 (enExample)
EA (1) EA016764B1 (enExample)
ES (1) ES2353683T3 (enExample)
HR (1) HRP20110107T1 (enExample)
MX (1) MX2010000367A (enExample)
MY (1) MY148077A (enExample)
PL (1) PL2170415T3 (enExample)
PT (1) PT2170415E (enExample)
SI (1) SI2170415T1 (enExample)
UA (1) UA28103U (enExample)
WO (1) WO2009008851A2 (enExample)
ZA (1) ZA201000126B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079209A2 (en) * 2009-01-08 2010-07-15 Golub Alexandr A Compositions for treating wounds and skin conditions
MD4197C1 (ro) * 2012-10-22 2013-09-30 Мария ДАНУ Metodă de tratament al ulcerelor trofice
CN102961336B (zh) * 2012-12-13 2014-08-13 清华大学深圳研究生院 纳米级铂类药物及其制备方法
BR112016010351A2 (pt) * 2013-11-06 2017-08-08 Invenres Gmbh Composições em forma de pó, métodos de produção de uma composição em forma de pó, preparação farmacêutica, e artigo médico
EP3215129A2 (en) * 2014-11-04 2017-09-13 invenres GmbH Pharmaceutical preparation and method of its production and use
CN106558599B (zh) * 2015-09-29 2020-04-07 中芯国际集成电路制造(上海)有限公司 电阻随机存取存储器及其形成方法
JP7475052B2 (ja) 2018-01-29 2024-04-26 パテレン・ヘルス・ケア・アクチェンゲゼルシャフト 親水性／疎水性薬学的組成物、ならびにその産生法および使用法
CN108309941B (zh) * 2018-03-20 2023-08-11 南京工业大学 一种舍雷肽酶外用粉剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485095A (en) * 1981-08-10 1984-11-27 Kaken Pharmaceutical Co., Ltd. Pronase used for the treatment of diseases of the liver and kidneys in humans and animals
CN1527729A (zh) * 2001-07-24 2004-09-08 \ 局部用药物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792160A (en) * 1972-01-18 1974-02-12 Takeda Chemical Industries Ltd Method of treating inflammation and composition therefor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485095A (en) * 1981-08-10 1984-11-27 Kaken Pharmaceutical Co., Ltd. Pronase used for the treatment of diseases of the liver and kidneys in humans and animals
CN1527729A (zh) * 2001-07-24 2004-09-08 \ 局部用药物制剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Manish Maheshwari et al..Development of Tetracycline-Serratiopeptidase-Containing Periodontal Gel: Formulation and Preliminary Clinical Study.《AAPS PharmSciTech》.2006,第7卷(第3期),E1-E10. *

Also Published As

Publication number Publication date
CA2693087A1 (en) 2009-01-15
AU2008275852B2 (en) 2014-02-13
EP2170415A2 (en) 2010-04-07
UA28103U (uk) 2007-11-26
PL2170415T3 (pl) 2011-04-29
MX2010000367A (es) 2010-07-02
WO2009008851A3 (en) 2009-11-26
DK2170415T3 (da) 2010-12-13
US10166275B2 (en) 2019-01-01
JP5464750B2 (ja) 2014-04-09
JP2010533174A (ja) 2010-10-21
CY1111652T1 (el) 2015-10-07
KR101482960B1 (ko) 2015-01-15
MY148077A (en) 2013-02-28
WO2009008851A2 (en) 2009-01-15
EP2277559A1 (en) 2011-01-26
PT2170415E (pt) 2011-01-05
US20160206709A1 (en) 2016-07-21
CN101772356A (zh) 2010-07-07
US9757436B2 (en) 2017-09-12
KR20100051655A (ko) 2010-05-17
EP2170415B1 (en) 2010-11-17
EA016764B1 (ru) 2012-07-30
EA201070130A1 (ru) 2010-08-30
ES2353683T3 (es) 2011-03-04
AU2008275852A1 (en) 2009-01-15
US20100291062A1 (en) 2010-11-18
CA2693087C (en) 2016-08-16
DE602008003584D1 (de) 2010-12-30
ATE488255T1 (de) 2010-12-15
HRP20110107T1 (hr) 2011-03-31
ZA201000126B (en) 2011-04-28
US20170368154A1 (en) 2017-12-28
SI2170415T1 (sl) 2011-02-28
BRPI0814549B1 (pt) 2018-07-03
US20150297787A1 (en) 2015-10-22
BRPI0814549A2 (pt) 2017-10-03
US9302027B2 (en) 2016-04-05

Similar Documents

Publication Publication Date Title
US10166275B2 (en) Antimicrobial composition comprising pyrogenic silica and serrathiopeptidase and uses thereof
AU2013235883A1 (en) Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections
CN105169455B (zh) 一种烧烫伤外用急救医用敷料及其制备方法
US20250144133A1 (en) Colestyramine for treating wounds, bacterial infections of the skin, and inflammatory skin lesions
RU2185149C1 (ru) Ранозаживляющее средство "витамустим-гель" (варианты), способ его приготовления и способ лечения им поврежденой кожи, ран, ожогов и трофических язв
HK1145817B (en) Antimicrobial composition
HK1145817A (en) Antimicrobial composition
CN108635362B (zh) 一种治疗糖尿病足的药物组合物
CN110974810A (zh) 成膜型护创液及其制备方法与应用
RU2115436C1 (ru) Средство для лечения ран
Jones Use of hydrogels and iodine in diabetic foot lesions
RU2470629C1 (ru) Способ комплексного лечения абсцессов и флегмон челюстно-лицевой области у детей мазью с фурацилином, лидокаином и дибунолом
RU2455997C2 (ru) Способ лечения инфицированных ожоговых ран iiia степени
UA64934A (en) Complex antibacterial sorption preparation benegol for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and wounds and method for its manufacture
CN108434512A (zh) 一种用于术后处理的医用冷敷凝胶及其制备方法
Abali et al. Our Experience on Topical Usage of Acetic Acid in Pediatric Major Burns
WO2010020198A1 (zh) 一种使病变组织脱水、萎缩的药物组合物
Youssef et al. Development of the composition of extemporaneous ointment on the basis of sorbent for wounds treatment
RU2445075C1 (ru) Способ комплексного лечения абсцессов и флегмон челюстно-лицевой области у детей мазью с фурацилином, лидокаином и дибунолом
Біляєва Comparative Clinical Study of the Wound Healing Effects of a Novel Micropore Particle Technology: Effects on Wounds, Venous Leg Ulcers, and Diabetic Foot Ulcers
JP2004083557A (ja) 創傷用外用剤
WO2012108851A1 (ru) Композиция для лечения гнойных ран
UA65716A (en) Complex antibacterial sorption composition "benegol forte" for preventing anaerobic infection and treating purulent wounds, neurepathic eschar, and burns, method for its manufacture and application
CN103501778A (zh) 用于治疗和/或预防皮肤损伤的感染的外用药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1145817

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1145817

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130508